Register to receive a free U.S. Market Report Suite for Hearing Devices – MedSuite report synopsis and brochure
Oticon Medical announced the launch of Ponto 4, a breakthrough in bone anchored hearing care, on March 27th, 2019 at AudiologyNOW conference in Columbus, Ohio.
This state-of-the-art sound processor is built on the one-of-a-kind Velox S™ platform, enabling Ponto 4 to achieve precision and speed for an open sound scape and optimized listening experience. The unique Open Sound Navigator™ examines the auditory experience by more than 100x per second, which equalizes the sound sources and reduces noise between words, thus leading to a concise and accurate enhanced version of the original auditory data.
“Oticon Medical will, in 2019, enter a new era by bringing the largest improvements for bone anchored users in many years”, explains Jes Olsen, President of Oticon Medical. “The introduction of Ponto 4 and the Velox S™ platform marks a paradigm shift in bone anchored hearing. Many users around the world have already had their lives changed by the groundbreaking technology in Oticon Opn and Opn S hearing aids. Now, we combine our know-how on bone conduction hearing with the newest state-of-the-art technology from one of the world’s leading hearing healthcare groups.”
Ponto 4 is the smallest bone anchored device on the market, 27% smaller than Ponto 3. The exclusive design is built on the pinnacle of Ponto reliability and durability to move with each user on their day-to-day activities. Ponto 4 is currently pending FDA clearance.
“With Ponto 4, we are moving away from using directionality as we know it. The OpenSound Navigator handles multiple speech and noise sources in a new, fast and efficient way. It balances the environment and targets noise to a much higher degree that we have been able to before,” says Olsen.
According to research from iData Research, even amidst Cochlear America’s monopoly, technological innovation contributed to grow in this market. Although there is demand for a more innovative solutions, there have been significant improvements in sound processing and the expansion of features and accessories with newer versions of the device. Oticon’s Ponto has a new minimally invasive surgical procedure which has been substantially stealing market share from Cochlear.
iData reports that one driving trend in the hearing device market is the continual focus on product innovation. Technological innovations in hearing aid circuitry enhance sound quality and immediate post-fit satisfaction, as well as creating new features. Technological advances, which are first delivered in a manufacturer’s flagship or premium device, will trickle down through the rest of the product line, driving the growth of premium models as well stimulating movement in the lower-tier devices. Oticon Medical is paving the way with Ponto 4’s advanced bone anchored hearing technology capabilities.